institutions 49.59 65.89 16.30 32.87 Trade and other account payables 17.23 15.41 (1.82) (10.56) Current portion of lease liabilities 4.16 4.22 0.06 1.44 Lease liabilities 5.61 4.53 (1.08) (19.25) Total
, intangible assets of Baht 251.59 million, goodwill of Baht 222.21 million, current portion of finance lease receivable due within 1 year of Baht 129.63 million, investment in associate of Baht 139.11 million
ในหน่ึงปี (Current portion) 538 204 หุ้นกูท่ี้ถึงก าหนดช าระภายในหน่ึงปี (Current portion) 127 136 เงินกูย้มืระยะยาว (Non-current portion) 3,568 1,434 หุ้นกู ้(Non-current portion) 1,973 2,091 เงนิสด
International Aviation Company Limited 45 percent 45 percent The Company's portion of investment in U-Tapao International Aviation Company Limited 2,025 4,050 The completion date of the share purchased: June 16
4,987.6 million as at the end of Q3/2018, as the Company has repaid debenture and some portion of the borrowings. 6. Finance Costs Unit: THB Million, % 42.5 48.1 50.5 128.2 138.5 Q3/18 Q2/19 Q3/19 9M/18 9M
58,865 at the end of fiscal year 2016. There were both short-term and long- term borrowings totally 53,806 million baht. The portion of long-term borrowings was 37,179 million baht or represented 69% of
Financial Position (Baht million) Ending 31 December 2016 (Unit: Million Baht) 2016 2015 Asset 2,175.73 2,613.16 Intangible Assets - - Liability 1,909.09 2,493.93 Non-controlling interest - - Shareholders
liabilities - Overdraft from financial institutions 18.60 246.74 1,019.50 - Trade and other payables 466.92 1,649.54 1,474.36 - Others 0.13 12.81 0.07 Liability 485.65 1,909.09 2,493.93 Shareholders’ equity
equivalent to 2.91 times due to lower inventory. Liability and Off-Balance-Sheet Management The Company disclosed in Note 23 of the financial statements and consolidated financial report as of 31st December
Ratios Return on assets4 (%) 22.4% 9.8% 11.3% Liability to Equity (times) 0.2 0.6 0.6 Return on fixed assets5 (%) 145.2% 45.5% 49.4% Debt to equity (times) 0.0 0.3 0.3 Asset turnover 0.8 0.5 0.6 7 MD&A 2Q